863.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $863.42, with a volume of 465.58K.
It is up +0.07% in the last 24 hours and down -8.24% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$862.79
Open:
$861.84
24h Volume:
465.58K
Relative Volume:
0.62
Market Cap:
$105.76B
Revenue:
$397.96B
Net Income/Loss:
$4.55B
P/E Ratio:
24.84
EPS:
34.7654
Net Cash Flow:
$9.64B
1W Performance:
-0.89%
1M Performance:
-8.24%
6M Performance:
+9.03%
1Y Performance:
+24.62%
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MCK
Mckesson Corporation
|
863.42 | 105.68B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
317.58 | 62.23B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
211.83 | 50.58B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
77.42 | 8.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
2.21 | 2.02B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference - Yahoo
MCKESSON CORP (NYSE:MCK) Emerges as a Top Affordable Growth Stock - ChartMill
Evercore ISI Lowers McKesson (MCK) Target, Adds to Tactical Underperform List - Insider Monkey
Investors heavily search McKesson Corporation (MCK): Here is what you need to know - MSN
McKesson (NYSE: MCK) EVP, CIO and CTO Fraga details initial stock and RSU holdings - Stock Titan
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
Rx Savings Solutions founder alleges McKesson sabotaged company after $600M sale - The Business Journals
Castellan Group Takes Position in McKesson Corporation $MCK - National Today
Will Analyst Revisions And A CFO Transition Reshape McKesson's (MCK) Investment Narrative? - simplywall.st
Is It Time To Reassess McKesson (MCK) After Recent Share Price Pullback? - Yahoo Finance
McKesson to close West Seneca warehouse, cutting 78 jobs - Buffalo News
Triad Wealth Partners Buys 1,944 Shares of McKesson Corporation - National Today
McKesson Corporation stock (US58155Q1031): Is its healthcare distribution edge strong enough to unlo - AD HOC NEWS
Pharmaceutical distributor to close West Seneca site, lay off 78 - The Business Journals
McKesson CFO Transition Puts Capital Allocation And Valuation In Focus - simplywall.st
McKesson Corp (NYSE:MCK): A Strong Growth Stock Nears a Technical Breakout - ChartMill
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
McKesson (MCK) Advances But Underperforms Market: Key Facts - Yahoo Finance
McKesson Corp. stock rises Wednesday, still underperforms market - MarketWatch
McKesson (MCK) Sees Price Target Adjustment by Evercore ISI Grou - GuruFocus
McKesson (MCK) Target Price Adjusted by Evercore ISI - GuruFocus
Evercore ISI lowers McKesson stock price target to $950 on growth concerns - Investing.com UK
BofA Lowers McKesson (MCK) Price Target, Flags GLP-1 Pricing Pressure - Insider Monkey
Will McKesson (MCK) Surpass Expectations in Its Upcoming Earnings Announcement? - Bitget
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
McKesson Secures New $2 Billion Senior Credit Facilities - The Globe and Mail
Leerink Partners Remains Bullish on McKesson Corporation (MCK), Retains a $785 Price Target - MSN
Mckesson Corp Stock (MCK) Closed Down by 3.20% on Apr 6: Key Drivers Unveiled - TradingKey
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
McKesson Corporation (MCK) Enters into Significant Credit Agreem - GuruFocus
McKesson Corporation 2026 Credit Agreement: Key Terms, Covenants, and Financial Definitions Explained - Minichart
McKesson (MCK) Price Target Lowered by B of A Securities | MCK S - GuruFocus
McKesson (NYSE:MCK) Price Target Lowered to $1,000.00 at Bank of America - MarketBeat
McKesson Corpsubsidiaries enter credit agreement on April 1, 2026SEC filing - marketscreener.com
Mckesson CorpSubsidiaries Enter Credit Agreement On April 1, 2026SEC Filing - TradingView — Track All Markets
McKesson Secures $2.0 Billion Senior Secured Credit Facilities Led by JPMorgan - TradingView
[8-K] MCKESSON CORP Reports Material Event - Stock Titan
Rathbones Group PLC Sells 14,594 Shares of McKesson Corporation $MCK - MarketBeat
BofA cuts McKesson stock price target on GLP-1 headwinds By Investing.com - Investing.com India
BofA cuts McKesson stock price target on GLP-1 headwinds - Investing.com
Assessing McKesson (MCK) Valuation After Upward Earnings Revisions And Strength In Pharmaceutical Distribution - simplywall.st
McKesson Corporation (MCK) Stock Price, News, Quote & History - Yahoo! Finance Canada
McKesson Wound Care Solutions: Essential B2B and Homecare Products Driving Healthcare Efficiency in - AD HOC NEWS
Gavin Newsom Hails Apple's '50 Years Of Innovation' As Tesla, Chevron, McKesson Leave California - Yahoo Finance
Should Upgraded EPS Forecasts and Revenue Momentum Require Action From McKesson (MCK) Investors? - Yahoo Finance
Here's Why We Think McKesson (NYSE:MCK) Is Well Worth Watching - Yahoo Finance
Lau Michele, McKesson Corp EVP, sells $2.69m in stock - Investing.com
Do Earnings Revisions And Value-Based Care Momentum Change The Bull Case For McKesson (MCK)? - simplywall.st
McKesson (MCK) Outperforms Broader Market: What You Need to Know - finance.yahoo.com
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson Corporation $MCK Stock Holdings Increased by HF Advisory Group LLC - MarketBeat
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):